Upcoming forum – Call me by any name: the facts on meth and Hep A, B and C

SAMESH & Hepatitis SA, August 2018

Crystal? Ice? Tina? Have questions about methamphetamines?

Want to know the facts? How to look after yourself and others?

Curious about hepatitis A, B or C? Want to know more about transmission and treatment?

Come to our community forum & have your questions answered by experts.

Speakers: Gary Spence & Michelle Spudic – from Hepatitis SA

FREE EVENT

Date: 30 August 2018
Time: 6.30 PM – 8 PM
Location: SAMESH, 57 Hyde Street Adelaide

RSVP Register at samesh-enquiries@samesh.org.au
or call (08) 7099 5300

Download flyer here: CMBAN_Poster

Media coverage of methamphetamine use in SA “demonising”

InDaily Adelaide, August 1, 2018

The head of South Australia’s drug and alcohol services network says recent reports on the use of methamphetamine in the workplace are misleading and could cause people to turn away from seeking treatment.

 

Chemsex: film screening and panel discussion

SAMESH, November 2017

Chemsex is a documentary that exposes the other side to modern gay life, telling
the story of gay men struggling to make it out of ‘the scene’ alive. This powerful and unflinching film followers a group of men battling with HIV, drug addiction, and finding acceptance in a changing world.

The screening will be followed by a discussion about the film with an Alcohol and Other Drug specialist in an attendance to provide insight.

We encourage clinicians and nurses to attend the CHEMSEX film. The use of ICE/Meth within the MSM community is increasing and we need to develop appropriate services to support these vulnerable community members.

Details:

Wednesday 22 NOVEMBER, 6 PM – 8 PM
57 Hyde Street Adelaide
Free entry – please note this is an 18+ event

Download flyer: Feast_2017_Events_Chemsex

 

 

Australian Needle and Syringe Program Survey: National Data Report 2012 – 2016

The Kirby Institute, UNSW, May 2017

The Australian Needle and Syringe Program Survey (ANSPS) provides serial point prevalence estimates of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) antibodies and sexual and injecting risk behaviour among people who inject drugs (PWID) in Australia.
Conducted annually over a one-two week period in October, all clients attending participating needle and syringe program (NSP) services are invited to complete a brief, anonymous questionnaire and to provide a capillary blood sample for HIV and HCV antibody testing.
This report presents national and state/territory data for the period 2012 to 2016.

Key findings:

  • In 2016, 50 Australian Needle and Syringe Programs (NSPs) participated in the ANSPS and 2,210 NSP attendees completed the survey. The response rate was 41%.
  • Over the period 2012 to 2016, the median age of survey respondents increased from 38 years to 42 years, with a concurrent decrease in the proportion of young injectors (aged <25 years) from 7% in 2012 to 4% in 2016.
  • HIV antibody prevalence remained low and stable nationally, ranging from 1.2% to 2.1% over the period 2012 to 2016
  • Hepatitis C virus (HCV) antibody prevalence was stable over the period 2012 to 2016, ranging from 51% to 57%.
  • Nationally, the proportion of respondents who reported recent (last 12 months) initiation of HCV treatment was low and stable at 1-3% between 2011-2015, but increased significantly to 22% in 2016, with substantial increases observed in all jurisdictions.

Download Australian Needle and Syringe Program Survey: National Data Report 2012 – 2016 (PDF) 

STI rates in PrEP users very high, but evidence that PrEP increases them is inconclusive

nam/aidsmap, Published: 22 February 2017
A study of PrEP users presented last week showed that PrEP users had very high rates of STI diagnosis – in the order of 20 times higher than among HIV-negative gay men in the general population. The evidence that STIs increased further while people were on PrEP was, however, a lot more ambiguous.
The problem in proving that PrEP has any causal relationship to STIs is that STIs among gay men were, in general, rising before well before PrEP, and also that PrEP usually involves regular testing for HIV and STIs. Since many STIs are asymptomatic and self-limiting, more tests will result in more diagnoses.
Read more here 

Methamphetamine use in Adelaide climbs as SA calls for action on drug ‘scourge’

ABC news, 25.01.2017

Methamphetamine use in Adelaide rose 25 per cent in the past year and tripled over five years, an analysis of the city’s sewage has shown.

Read more here